annual EBIT:
$220.11M+$21.59M(+10.88%)Summary
- As of today (July 27, 2025), AMPH annual earnings before interest & taxes is $220.11 million, with the most recent change of +$21.59 million (+10.88%) on December 31, 2024.
- During the last 3 years, AMPH annual EBIT has risen by +$135.08 million (+158.88%).
- AMPH annual EBIT is now at all-time high.
Performance
AMPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$37.15M-$13.24M(-26.27%)Summary
- As of today (July 27, 2025), AMPH quarterly earnings before interest & taxes is $37.15 million, with the most recent change of -$13.24 million (-26.27%) on March 31, 2025.
- Over the past year, AMPH quarterly EBIT has dropped by -$19.34 million (-34.24%).
- AMPH quarterly EBIT is now -51.97% below its all-time high of $77.34 million, reached on September 30, 2023.
Performance
AMPH quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$200.77M-$19.34M(-8.79%)Summary
- As of today (July 27, 2025), AMPH TTM earnings before interest & taxes is $200.77 million, with the most recent change of -$19.34 million (-8.79%) on March 31, 2025.
- Over the past year, AMPH TTM EBIT has dropped by -$20.27 million (-9.17%).
- AMPH TTM EBIT is now -17.54% below its all-time high of $243.48 million, reached on June 30, 2024.
Performance
AMPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMPH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | -34.2% | -9.2% |
| 3 y3 years | +158.9% | +26.4% | +83.9% |
| 5 y5 years | +264.7% | +531.7% | +2671.1% |
AMPH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.9% | -52.0% | +60.4% | -17.5% | +94.1% |
| 5 y | 5-year | at high | +4292.5% | -52.0% | +658.3% | -17.5% | +4517.5% |
| alltime | all time | at high | +803.1% | -52.0% | +470.8% | -17.5% | +775.5% |
AMPH EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $37.15M(-26.3%) | $200.77M(-8.8%) |
| Dec 2024 | $220.11M(+10.9%) | $50.39M(-7.3%) | $220.11M(-0.2%) |
| Sep 2024 | - | $54.38M(-7.6%) | $220.52M(-9.4%) |
| Jun 2024 | - | $58.85M(+4.2%) | $243.48M(+10.2%) |
| Mar 2024 | - | $56.49M(+11.2%) | $221.04M(+11.3%) |
| Dec 2023 | $198.52M(+68.4%) | $50.80M(-34.3%) | $198.52M(+4.8%) |
| Sep 2023 | - | $77.34M(+112.4%) | $189.50M(+40.0%) |
| Jun 2023 | - | $36.41M(+7.2%) | $135.33M(+10.5%) |
| Mar 2023 | - | $33.97M(-18.7%) | $122.47M(+3.9%) |
| Dec 2022 | $117.89M(+38.7%) | $41.79M(+80.4%) | $117.89M(+14.0%) |
| Sep 2022 | - | $23.16M(-1.6%) | $103.43M(-12.7%) |
| Jun 2022 | - | $23.55M(-19.9%) | $118.44M(+8.5%) |
| Mar 2022 | - | $29.39M(+7.5%) | $109.19M(+28.4%) |
| Dec 2021 | $85.02M(+1596.7%) | $27.33M(-28.4%) | $85.02M(+66.6%) |
| Sep 2021 | - | $38.17M(+166.9%) | $51.04M(+153.7%) |
| Jun 2021 | - | $14.30M(+174.1%) | $20.12M(+362.7%) |
| Mar 2021 | - | $5.22M(-178.4%) | $4.35M(-13.2%) |
| Dec 2020 | $5.01M(-91.7%) | -$6.65M(-191.7%) | $5.01M(-61.1%) |
| Sep 2020 | - | $7.25M(-593.7%) | $12.89M(+78.0%) |
| Jun 2020 | - | -$1.47M(-125.0%) | $7.25M(-89.6%) |
| Mar 2020 | - | $5.88M(+378.5%) | $69.83M(+15.7%) |
| Dec 2019 | $60.35M(-723.2%) | $1.23M(-23.4%) | $60.35M(+1.1%) |
| Sep 2019 | - | $1.60M(-97.4%) | $59.71M(-1.8%) |
| Jun 2019 | - | $61.12M(-1796.3%) | $60.80M(-1477.2%) |
| Mar 2019 | - | -$3.60M(-710.7%) | -$4.42M(-54.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$9.68M(-566.7%) | $590.00K(-78.1%) | -$9.68M(-14.2%) |
| Sep 2018 | - | $2.70M(-165.8%) | -$11.28M(-28.7%) |
| Jun 2018 | - | -$4.10M(-53.8%) | -$15.83M(+90.2%) |
| Mar 2018 | - | -$8.87M(+777.4%) | -$8.32M(-470.9%) |
| Dec 2017 | $2.08M(-86.7%) | -$1.01M(-45.4%) | $2.24M(-237.7%) |
| Sep 2017 | - | -$1.85M(-154.3%) | -$1.63M(-125.1%) |
| Jun 2017 | - | $3.41M(+101.2%) | $6.50M(-50.6%) |
| Mar 2017 | - | $1.70M(-134.7%) | $13.15M(-16.0%) |
| Dec 2016 | $15.65M(-266.9%) | -$4.88M(-177.8%) | $15.65M(-49.6%) |
| Sep 2016 | - | $6.28M(-37.5%) | $31.08M(+49.8%) |
| Jun 2016 | - | $10.06M(+139.5%) | $20.75M(+2956.7%) |
| Mar 2016 | - | $4.20M(-60.2%) | $679.00K(-107.2%) |
| Dec 2015 | -$9.38M(-46.5%) | $10.54M(-360.7%) | -$9.38M(-64.3%) |
| Sep 2015 | - | -$4.04M(-59.6%) | -$26.29M(-11.6%) |
| Jun 2015 | - | -$10.02M(+71.1%) | -$29.72M(+40.8%) |
| Mar 2015 | - | -$5.86M(-8.0%) | -$21.10M(+20.3%) |
| Dec 2014 | -$17.54M(-196.4%) | -$6.37M(-14.9%) | -$17.54M(+114.7%) |
| Sep 2014 | - | -$7.48M(+434.3%) | -$8.17M(+5069.6%) |
| Jun 2014 | - | -$1.40M(-38.9%) | -$158.00K(-101.2%) |
| Mar 2014 | - | -$2.29M(-176.3%) | $13.40M(-26.3%) |
| Dec 2013 | $18.18M(-31.8%) | $3.00M(+466.6%) | $18.18M(+19.8%) |
| Sep 2013 | - | $530.00K(-95.6%) | $15.18M(+3.6%) |
| Jun 2013 | - | $12.16M(+387.0%) | $14.65M(+487.0%) |
| Mar 2013 | - | $2.50M | $2.50M |
| Dec 2012 | $26.66M(-185.2%) | - | - |
| Dec 2011 | -$31.30M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AMPH is $220.11M
What is the all time high annual EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $220.11M
What is Amphastar Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AMPH annual earnings before interest & taxes has changed by +$21.59M (+10.88%)
What is Amphastar Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AMPH is $37.15M
What is the all time high quarterly EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $77.34M
What is Amphastar Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AMPH quarterly earnings before interest & taxes has changed by -$19.34M (-34.24%)
What is Amphastar Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AMPH is $200.77M
What is the all time high TTM EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $243.48M
What is Amphastar Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AMPH TTM earnings before interest & taxes has changed by -$20.27M (-9.17%)